JP Morgan Chase’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-759,991
| Closed | -$100M | – | 7888 |
|
|
2025
Q1 | $100M | Sell |
759,991
-4,366,101
| -85% | -$544M | 0.01% | 927 |
|
|
2024
Q4 | $428M | Sell |
5,126,092
-160,193
| -3% | -$13.2M | 0.03% | 421 |
|
|
2024
Q3 | $387M | Buy |
5,286,285
+1,851,053
| +54% | +$139M | 0.03% | 463 |
|
|
2024
Q2 | $235M | Buy |
3,435,232
+1,679,284
| +96% | +$116M | 0.02% | 599 |
|
|
2024
Q1 | $122M | Sell |
1,755,948
-316,667
| -15% | -$21.8M | 0.01% | 855 |
|
|
2023
Q4 | $148M | Buy |
2,072,615
+8,813
| +0.4% | +$507K | 0.02% | 718 |
|
|
2023
Q3 | $108M | Buy |
2,063,802
+86,388
| +4% | +$5.03M | 0.01% | 778 |
|
|
2023
Q2 | $125M | Buy |
1,977,414
+146,530
| +8% | +$9.13M | 0.01% | 728 |
|
|
2023
Q1 | $99.1M | Buy |
1,830,884
+332,970
| +22% | +$16.1M | 0.01% | 791 |
|
|
2022
Q4 | $79.3M | Buy |
1,497,914
+1,310,130
| +698% | +$65.7M | 0.01% | 879 |
|
|
2022
Q3 | $8.74M | Sell |
187,784
-1,433
| -0.8% | -$74.9K | ﹤0.01% | 2264 |
|
|
2022
Q2 | $10.8M | Buy |
189,217
+32,073
| +20% | +$1.82M | ﹤0.01% | 2095 |
|
|
2022
Q1 | $9.62M | Buy |
157,144
+16,454
| +12% | +$855K | ﹤0.01% | 2412 |
|
|
2021
Q4 | $7.36M | Sell |
140,690
-1,313
| -0.9% | -$55.2K | ﹤0.01% | 2717 |
|
|
2021
Q3 | $5.29M | Sell |
142,003
-2,091
| -1% | -$72.7K | ﹤0.01% | 2985 |
|
|
2021
Q2 | $5.88M | Sell |
144,094
-5,309
| -4% | -$196K | ﹤0.01% | 2917 |
|
|
2021
Q1 | $5.07M | Sell |
149,403
-10,200
| -6% | -$354K | ﹤0.01% | 2962 |
|
|
2020
Q4 | $5.08M | Sell |
159,603
-3,940
| -2% | -$104K | ﹤0.01% | 2803 |
|
|
2020
Q3 | $4.18M | Sell |
163,543
-2,719
| -2% | -$62K | ﹤0.01% | 2716 |
|
|
2020
Q2 | $4.27M | Buy |
166,262
+2,261
| +1% | +$45.8K | ﹤0.01% | 2577 |
|
|
2020
Q1 | $2.52M | Sell |
164,001
-215,318
| -57% | -$4.68M | ﹤0.01% | 2788 |
|
|
2019
Q4 | $13M | Buy |
379,319
+164,495
| +77% | +$1.97M | ﹤0.01% | 1906 |
|
|
2019
Q3 | $1.6M | Buy |
214,824
+4,293
| +2% | +$41.2K | ﹤0.01% | 3554 |
|
|
2019
Q2 | $2.67M | Sell |
210,531
-7,045
| -3% | -$90.4K | ﹤0.01% | 3177 |
|
|
2019
Q1 | $2.65M | Sell |
217,576
-31,824
| -13% | -$407K | ﹤0.01% | 3137 |
|
|
2018
Q4 | $2.84M | Buy |
249,400
+32,168
| +15% | +$519K | ﹤0.01% | 3021 |
|
|
2018
Q3 | $4.71M | Sell |
217,232
-39,263
| -15% | -$821K | ﹤0.01% | 2792 |
|
|
2018
Q2 | $4.53M | Sell |
256,495
-127,275
| -33% | -$2.58M | ﹤0.01% | 2769 |
|
|
2018
Q1 | $8.08M | Sell |
383,770
-133,537
| -26% | -$2.6M | ﹤0.01% | 2180 |
|
|
2017
Q4 | $7.49M | Buy |
517,307
+108,882
| +27% | +$1.68M | ﹤0.01% | 2351 |
|
|
2017
Q3 | $6.31M | Buy |
+408,425
| New | +$5.99M | ﹤0.01% | 2381 |
|
|
2017
Q2 | – | Sell |
-53,915
| Closed | -$876K | – | 5283 |
|
|
2017
Q1 | $876K | Sell |
53,915
-41,624
| -44% | -$602K | ﹤0.01% | 3467 |
|
|
2016
Q4 | $1.44M | Buy |
95,539
+93,339
| +4,243% | +$1.32M | ﹤0.01% | 3268 |
|
|
2016
Q3 | $34K | Sell |
2,200
-144,076
| -98% | -$5.83M | ﹤0.01% | 4100 |
|
|
2016
Q2 | $5.68M | Buy |
146,276
+99,051
| +210% | +$3.56M | ﹤0.01% | 2204 |
|
|
2016
Q1 | $1.31M | Buy |
47,225
+11,097
| +31% | +$370K | ﹤0.01% | 2927 |
|
|
2015
Q4 | $1.94M | Buy |
+36,128
| New | +$1.82M | ﹤0.01% | 2772 |
|
Other funds holding ITCI
KIM
HNB